Corporate COVID-19 Response Must Look Beyond Poison Pills - Law360 -BoardProspects

Corporate COVID-19 Response Must Look Beyond Poison Pills

Law360 May 2 2020 BoardBlogs

After years of tremendous economic growth, COVID-19 has unleashed unprecedented market volatility and extreme value dislocations for U.S. public companies. Senior management and directors are facing existential business model, strategic and human resource challenges that are generational in scope...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- Are You Ready for an Advisory Board? Twelve Questions to Help You Decide By: Susan Hammond also categorized in BoardBlogs
- Responsibilities of a Nonprofit Board by Maria Peeler also categorized in BoardBlogs
- Everyone Gets Rated By Leigh Tucker also categorized in BoardBlogs
- Nonprofit Governance: Why It Matters to Attend Board Meetings By Susan Hammond also categorized in BoardBlogs
- The 70:20:10 Rule of Board Learning by Debra Beck also categorized in BoardBlogs
- A New Year's Resolution for Boards By Mark Rogers also categorized in BoardBlogs
- Hewlett-Packard Shakes Up Management, Raises Outlook also mentions Management
- Katten Lures Corporate Governance Chair From Neal Gerber also published in Law360
- Is Your Board Meeting Location a Distraction? by Susan Hammond also categorized in BoardBlogs
- Who’s in charge here? By: Charles Whipple also categorized in BoardBlogs

Search:
Categories
1. BoardProspects Features:
  BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
Topics Mentioned